<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">endoserg</journal-id><journal-title-group><journal-title xml:lang="ru">Эндокринная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Endocrine Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-3513</issn><issn pub-type="epub">2310-3965</issn><publisher><publisher-name>Типография «Печатных дел Мастер»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/serg8800</article-id><article-id custom-type="elpub" pub-id-type="custom">endoserg-8800</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая практика</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical practice</subject></subj-group></article-categories><title-group><article-title>Результаты хирургического лечения больных первичным гиперпаратиреозом, сочетанным с уролитиазом: динамика клинических проявлений, лабораторных показателей и риска камнеобразования</article-title><trans-title-group xml:lang="en"><trans-title>Effectiveness of surgical treatment of primary hyperparathyroidism with urolithiasis: correction of symptoms, laboratory parameters and stone-forming risk</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6694-9030</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергийко</surname><given-names>Сергей Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Sergiyko</surname><given-names>Sergey V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, доцент, заведующий кафедрой Общей хирургии ЮУГМУ</p></bio><bio xml:lang="en"><p>MD, PhD, assistant professor</p></bio><email xlink:type="simple">ssv_1964@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6199-2141</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рогозин</surname><given-names>Дмитрий Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Rogozin</surname><given-names>Dmitriy S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ассистент кафедры Общей хирургии ЮУГМУ</p></bio><bio xml:lang="en"><p>MD, assistant lecturer</p></bio><email xlink:type="simple">rogozin.dmi@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБОУ ВО Южно-Уральский государственный медицинский университет Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;South-Ural State Medical University&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>03</day><month>03</month><year>2018</year></pub-date><volume>11</volume><issue>4</issue><fpage>191</fpage><lpage>200</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сергийко С.В., Рогозин Д.С., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Сергийко С.В., Рогозин Д.С.</copyright-holder><copyright-holder xml:lang="en">Sergiyko S.V., Rogozin D.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surg-endojournals.ru/jour/article/view/8800">https://www.surg-endojournals.ru/jour/article/view/8800</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Удаление гиперфункционирующих околощитовидных желез – единственный радикальный метод лечения первичного гиперпаратиреоза (ПГПТ), позволяющий устранить нарушения кальциево-фосфорного обмена, нивелировать клинические проявления, а также снизить риск камнеобразования у больных ПГПТ с уролитиазом. Однако не всеми специалистами признается существование изолированной почечной формы ПГПТ и эффективность хирургического лечения в отношении риска камнеобразования.</p></sec><sec><title>Цель</title><p>Цель. Оценить эффективность хирургического лечения больных ПГПТ с уролитиазом в отношении клинических, лабораторных проявлений, а также риска камнеобразования.</p></sec><sec><title>Методы</title><p>Методы. В проспективное наблюдательное контролируемое нерандомизированное моноцентровое исследование вошли больные ПГПТ, оперированные в период с 2012 по 2015 г. Анализировали динамику клинических и лабораторных проявлений ПГПТ и уролитиаза, в том числе суточную экскрецию кальция с мочой, и возникновение рецидивов уролитиаза в сроки от 1 до 3 лет.</p></sec><sec><title>Результаты</title><p>Результаты. В исследование вошли 105 пациентов с ПГПТ, в том числе 35 (33,3%) – с уролитиазом. После операции концентрация кальция в крови снизилась в группе с 2,74 ммоль/л [2,56; 2,97] до 2,3 ммоль/л [2,2; 2,35] (р &lt; 0,001), нормализовавшись у всех пациентов. Содержание паратгормона снизилось с 206 пг/мл [123; 347] до 72,8 пг/мл [30; 113] (р &lt; 0,001). Клинические проявления ПГПТ после хирургического лечения регрессировали, их балльная оценка, по данным опросника, снизилась с 4 [3; 6] до 2 [1; 4] (р &lt; 0,001). Отмечено, что у больных ПГПТ с уролитиазом исходно клинические симптомы были выражены ярче и составляли 5 баллов [3; 7] против 4 баллов [3; 5] у больных без уролитиаза (р = 0,015) и исчезали после оперативного лечения более значимо – балльная оценка снизилась на 3 балла [2; 4] и 2 балла [1; 3] соответственно. Суточная экскреция кальция снизилась после лечения с 11,4 ммоль/сут [8,9; 13,9] до 5,4 ммоль/сут [4,1; 6,8] (р &lt; 0,001). У 2 (5,7%) пациентов после операции отмечено прогрессирование уролитиаза. Возраст больных коррелировал с суточной экскрецией кальция после операции (r = 0,69; р = 0,028).</p></sec><sec><title>Заключение</title><p>Заключение. Своевременное хирургическое лечение ПГПТ нормализует содержание кальция и паратгормона в крови, позволяет достичь клинического улучшения и снизить риск камнеобразования.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Parathyroidectomy is the only effective method to improve the clinical and laboratory manifestations of the primary hyperparathyroidism (PHPT) and reduce the risk of urinary calculi formation. However, there are controversies about the existence of renal form of PHPT and about the effectiveness of surgery with regard to the risk of stone formation.</p></sec><sec><title>Aims</title><p>Aims. To evaluate the effectiveness of PHPT surgical treatment in relation to clinical, laboratory parameters, as well as the risk of stone formation.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. In a prospective single-arm observation one-center nonrandomized study we included patients with PHPT in whom parathyroidectomy was performed in 2012–2015. We analyzed clinical and laboratory parameters before and after surgery in a period from 1 to 3 years.</p></sec><sec><title>Results</title><p>Results. The study included 105 patients, of whom 35 (33.3%) had urolithiasis. Blood calcium after the surgery decreased from 2.72 mmol/l [2,56; 2,97] to 2,3 mmol/l [2,2; 2,35], p &lt; 0.001. Blood calcium concentration decreased to normal values in all patients. Parathyroid hormone level decreased from 206 pg/ml [123; 347] to 72,8 pg/ml [30; 113], p &lt; 0.001. Clinical symptoms questionnaire estmation decreased from 4 points [3; 6] to 2 points [1; 4], p &lt; 0.001. In patients with urolithiasis clinical symptoms before treatment were more pronounced – 5 points [3; 7] vs. 4 points [3; 5] (p = 0.015) and decreased more significantly – by 3 points [2; 4] vs 2 points [1; 3]. The daily calcium urine excretion decreased from 11.4 mmol/day [8.9; 13.9] to 5.4 mmol/day [4.1; 6.8], p &lt; 0.001. In 2 cases (5.7%; CI, 0.7–19.2%) we observed the progression of urolithiasis after surgery. The age of patients correlated with daily calcium urine excretion after surgery (r = 0.69; p = 0.028).</p></sec><sec><title>Conclusions</title><p>Conclusions. Parathyroidectomy normalizes blood calcium and parathyroid hormone, improves clinical symptoms and reduces the risk of stone formation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гиперкальциурия</kwd><kwd>паратиреоидэктомия</kwd><kwd>первичный гиперпаратиреоз</kwd><kwd>уролитиаз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypercalciuria</kwd><kwd>parathyroidectomy</kwd><kwd>primary hyperparathyroidism</kwd><kwd>urolithiasis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г. Первичный гиперпаратиреоз. Эпидемиология, клиника, современные принципы диагностики и лечения: Дис. … д-ра мед. наук. – М.; 2011. [Mokrysheva NG. Pervichniy giperparatireoz. Epidemiologiya, klinika, sovremennye principy diagnostiki i lecheniya[dissertation]. Moscow; 2011. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Мокрышева Н.Г. Первичный гиперпаратиреоз. Эпидемиология, клиника, современные принципы диагностики и лечения: Дис. … д-ра мед. наук. – М.; 2011. [Mokrysheva NG. Pervichniy giperparatireoz. Epidemiologiya, klinika, sovremennye principy diagnostiki i lecheniya[dissertation]. Moscow; 2011. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo LE, Wachtel H, Fraker D, Kelz R. Reoperative parathyroidectomy: who is at risk and what is the risk? J Surg Res. 2014;191(2):256-261. doi: 10.1016/j.jss.2014.05.073.</mixed-citation><mixed-citation xml:lang="en">Kuo LE, Wachtel H, Fraker D, Kelz R. Reoperative parathyroidectomy: who is at risk and what is the risk? J Surg Res. 2014;191(2):256-261. doi: 10.1016/j.jss.2014.05.073.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng SP, Lee JJ, Liu TP, et al. Quality of life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2015;94(23):e931. doi: 10.1097/MD.0000000000000931.</mixed-citation><mixed-citation xml:lang="en">Cheng SP, Lee JJ, Liu TP, et al. Quality of life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2015;94(23):e931. doi: 10.1097/MD.0000000000000931.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mollerup CL. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002;325(7368): 807-807. doi: 10.1136/bmj.325.7368.807.</mixed-citation><mixed-citation xml:lang="en">Mollerup CL. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002;325(7368): 807-807. doi: 10.1136/bmj.325.7368.807.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Urol Clin North Am. 2000;27(2): 275-285. doi: 10.1016/s0094-0143(05)70257-3.</mixed-citation><mixed-citation xml:lang="en">Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Urol Clin North Am. 2000;27(2): 275-285. doi: 10.1016/s0094-0143(05)70257-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Berger AD, Wu W, Eisner BH, et al. Patients with primary hyperparathyroidism – why do some form stones? J Urol. 2009;181(5):2141-2145. doi: 10.1016/j.juro.2009.01.028.</mixed-citation><mixed-citation xml:lang="en">Berger AD, Wu W, Eisner BH, et al. Patients with primary hyperparathyroidism – why do some form stones? J Urol. 2009;181(5):2141-2145. doi: 10.1016/j.juro.2009.01.028.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Palmieri S, Eller-Vainicher C, Cairoli E, et al. Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia. J Clin Endocrinol Metab. 2015;100(7):2734-2742. doi: 10.1210/jc.2014-4548.</mixed-citation><mixed-citation xml:lang="en">Palmieri S, Eller-Vainicher C, Cairoli E, et al. Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia. J Clin Endocrinol Metab. 2015;100(7):2734-2742. doi: 10.1210/jc.2014-4548.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Webb SM, Puig-Domingo M, Villabona C, et al. Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013;11:97. doi: 10.1186/1477-7525-11-97.</mixed-citation><mixed-citation xml:lang="en">Webb SM, Puig-Domingo M, Villabona C, et al. Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013;11:97. doi: 10.1186/1477-7525-11-97.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Usta A, Alhan E, Cinel A, et al. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015;100(4):648-655. doi: 10.9738/INTSURG-D-14-00094.1.</mixed-citation><mixed-citation xml:lang="en">Usta A, Alhan E, Cinel A, et al. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015;100(4):648-655. doi: 10.9738/INTSURG-D-14-00094.1.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Рожинская Л.Я. Современные представления об этиологии, клинической картине, диагностике и лечении первичного гиперпаратиреоза. // Лечащий врач. – 2009. – №3. – С. 22–27. [Rozhinskaya LY. Sovremennye predstavleniya ob etiologii, klinicheskoy kartine, diagnostike ilechenii pervichnogo giperparatireoza. Lechaschiy vrach. 2009;(3): 22-27. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Рожинская Л.Я. Современные представления об этиологии, клинической картине, диагностике и лечении первичного гиперпаратиреоза. // Лечащий врач. – 2009. – №3. – С. 22–27. [Rozhinskaya LY. Sovremennye predstavleniya ob etiologii, klinicheskoy kartine, diagnostike ilechenii pervichnogo giperparatireoza. Lechaschiy vrach. 2009;(3): 22-27. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gopal RA, Acharya SV, Bandgar T, et al. Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med. 2010;56(2):79-84. doi: 10.4103/0022-3859.65279.</mixed-citation><mixed-citation xml:lang="en">Gopal RA, Acharya SV, Bandgar T, et al. Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med. 2010;56(2):79-84. doi: 10.4103/0022-3859.65279.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Starup-Linde J, Waldhauer E, Rolighed L, et al. Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Eur J Endocrinol. 2012;166(6):1093-1100. doi: 10.1530/EJE-12-0032.</mixed-citation><mixed-citation xml:lang="en">Starup-Linde J, Waldhauer E, Rolighed L, et al. Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Eur J Endocrinol. 2012;166(6):1093-1100. doi: 10.1530/EJE-12-0032.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Алаев Д.С., Котова И.В. Нефролитиаз при первичном гиперпаратиреозе. // Альманах клинической медицины. – 2013. – №28. – С. 58–60. [Alaev DS, Kotova IV. Nephrolithiasis in primary hyperparathyroidism. Almanac of clinical medicine. 2013;(28):58-60. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Алаев Д.С., Котова И.В. Нефролитиаз при первичном гиперпаратиреозе. // Альманах клинической медицины. – 2013. – №28. – С. 58–60. [Alaev DS, Kotova IV. Nephrolithiasis in primary hyperparathyroidism. Almanac of clinical medicine. 2013;(28):58-60. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Norman J, Goodman A, Politz D. Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocr Pract. 2011;17(3):384-394. doi: 10.4158/EP09346.OR.</mixed-citation><mixed-citation xml:lang="en">Norman J, Goodman A, Politz D. Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocr Pract. 2011;17(3):384-394. doi: 10.4158/EP09346.OR.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Black CE, Berg RL, Urquhart AC. 24-hour urinary calcium in primary hyperparathyroidism. Clin Med Res. 2013;11(4): 219-225. doi: 10.3121/cmr.2013.1164.</mixed-citation><mixed-citation xml:lang="en">Black CE, Berg RL, Urquhart AC. 24-hour urinary calcium in primary hyperparathyroidism. Clin Med Res. 2013;11(4): 219-225. doi: 10.3121/cmr.2013.1164.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sorensen MD, Duh QY, Grogan RH, et al. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012;151(3):477-483. doi: 10.1016/j.surg.2011.07.039.</mixed-citation><mixed-citation xml:lang="en">Sorensen MD, Duh QY, Grogan RH, et al. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012;151(3):477-483. doi: 10.1016/j.surg.2011.07.039.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
